Metadata Search
Alexion Pharmaceuticals
Page 1 of 124 results
Sort by: relevance publication year Download as CSV

Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria: Expert consensus

Journal Article published 16 May 2018 in European Journal of Haematology volume 101 issue 1 on pages 3 to 11

Research funded by Alexion Pharmaceuticals

Authors: Alexander Röth, Jaroslaw Maciejewski, Jun-Ichi Nishimura, Deepak Jain, Jeffrey I. Weitz

Patient-derived lymphoblastoid cell lines harboring mitochondrial DNA mutations as tool for small molecule drug discovery

Journal Article published 27 Mar 2018 in BMC Research Notes volume 11 issue 1

Research funded by Alexion Pharmaceuticals

Authors: Randall Marcelo Chin, Tadas Panavas, Jeffrey M. Brown, Krista K. Johnson

Bone mineral density is compromised in very long-term survivors of irradiated childhood brain tumor

Journal Article published 27 Jan 2018 in Acta Oncologica volume 57 issue 5 on pages 665 to 674

Research funded by Foundation of Märta Donner | Foundation of Emil Aaltonen | Pfizer | AbbVie | Alexion Pharmaceuticals | Foundation of Alma and K.A. Snellman | Novo | Lasten Syöpäsäätiö Väreen | Foundation of Arvo and Lea Ylppö | Syöpäjärjestöt | Oulu University Hospital | Cancer Foundation of Northern Finland | Shire | Special State Grants for Health Research in Department of Pediatrics and Adolescence | Merck | Emil Aaltosen Säätiö | Novo Nordisk | Foundation of Thelma Mäkikyrö | Lastentautien Tutkimussäätiö | Bayer | Foundation of Päivikki and Sakari Sohlberg

Authors: Tiina M. Remes, Pekka M. Arikoski, Päivi M. Lähteenmäki, Mikko O. Arola, Tytti M.-L. Pokka, V. Pekka Riikonen, Kirsti H. Sirkiä, Heikki M. J. Rantala, Arja H. Harila-Saari, Marja K. Ojaniemi

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes

Journal Article published Jun 2017 in Biology of Blood and Marrow Transplantation volume 23 issue 6 on pages 971 to 979

Research funded by National Cancer Institute (5U24-CA076518) | National Heart, Lung, and Blood Institute (5U10HL069294) | National Institute of Allergy and Infectious Diseases | Health Resources and Services Administration (HHSH250201200016C) | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Alexion Pharmaceuticals | Amgen

Authors: Aaron T. Gerds, Kwang Woo Ahn, Zhen-Huan Hu, Hisham Abdel-Azim, Gorgun Akpek, Mahmoud Aljurf, Karen K. Ballen, Amer Beitinjaneh, Ulrike Bacher, Jean-Yves Cahn, Saurabh Chhabra, Corey Cutler, Andrew Daly, Zachariah DeFilipp, Robert Peter Gale, Usama Gergis, Michael R. Grunwald, Gregory A. Hale, Betty Ky Hamilton, Madan Jagasia, Rammurti T. Kamble, Tamila Kindwall-Keller, Taiga Nishihori, Richard F. Olsson, Muthalagu Ramanathan, Ayman A. Saad, Melhem Solh, Celalettin Ustun, David Valcárcel, Erica Warlick, Baldeep M. Wirk, Matt Kalaycio, Edwin Alyea, Uday Popat, Ronald Sobecks, Wael Saber

Relevance of DC-SIGN in DC-induced T cell proliferation

Journal Article published 29 Nov 2006 in Journal of Leukocyte Biology volume 81 issue 3 on pages 729 to 740

Research funded by Alexion Pharmaceuticals

Authors: Karlijn Gijzen, Paul J. Tacken, Aukje Zimmerman, Ben Joosten, I. Jolanda M. de Vries, Carl G. Figdor, Ruurd Torensma

Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial

Journal Article published Dec 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 12 on pages 2256 to 2263

Research funded by Novartis Pharmaceuticals Corporation | National Marrow Donor Program | National Cancer Institute (CA160684, 5U24-CA076518) | Patient-Centered Outcomes Research Institute | Roswell Park Cancer Institute | Takeda Oncology | Medical College of Wisconsin | Pfizer | Leukemia and Lymphoma Society | Alexion Pharmaceuticals | Otsuka Pharmaceutical Co, Ltd. – Japan | Fred Hutchinson Cancer Research Center | WellPoint | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Janssen Scientific Affairs, LLC | Gamida Cell Ltd. | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | National Heart, Lung, and Blood Institute (U10HL069294, N00014-15-1-0848, N00014-16-1-2020, 5U10HL069294) | Swedish Orphan Biovitrum, Inc. | Miltenyi Biotec | National Institutes of Health (UL1TR001436, KL2TR001438) | Optum Healthcare Solutions, Inc. | MesoScale Diagnostics, Inc. | HistoGenetics | Spectrum Pharmaceuticals | Genentech | National Center for Advancing Translational Sciences | Mesoblast | Genzyme | GmbH | Medac | Telomere Diagnostics, Inc. | Sunesis Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Health Research | Gilead Sciences | Otsuka America Pharmaceutical | Neovii Biotech NA, Inc. | Health Resources and Services Administration (HHSH250201200016C) | Cellular Dynamics International, Inc. | Celgene | AstraZeneca | Merck | MedImmune | St. Baldrick's Foundation | Be The Match Foundation | Amgen | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | Bluebird Bio, Inc. | Astellas Pharma US | Incyte Corporation | Bristol-Myers Squibb Foundation

Authors: Jennifer M. Knight, Karen L. Syrjala, Navneet S. Majhail, Michael Martens, Jennifer Le-Rademacher, Brent R. Logan, Stephanie J. Lee, Paul B. Jacobsen, William A. Wood, Heather S.L. Jim, John R. Wingard, Mary M. Horowitz, Muneer H. Abidi, Mingwei Fei, Laura Rawls, J. Douglas Rizzo

Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations

Journal Article published Apr 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 4 on pages 744 to 751

Research funded by Novartis Pharmaceuticals Corporation | National Marrow Donor Program | National Cancer Institute (5U24-CA076518) | U.S. Public Health Service | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | Medical College of Wisconsin | Pharmacyclics | TerumoBCT | Leukemia and Lymphoma Society | Bristol-Myers Squibb | Therakos | Alexion Pharmaceuticals | Fred Hutchinson Cancer Research Center | WellPoint | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Gamida Cell Ltd. | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | National Heart, Lung, and Blood Institute (5U10HL069294) | Swedish Orphan Biovitrum, Inc. | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Optum Healthcare Solutions, Inc. | HistoGenetics | Spectrum Pharmaceuticals | Genentech | Mesoblast | Genzyme | Telomere Diagnostics, Inc. | Sunesis Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Health Research | Gilead Sciences | Otsuka America Pharmaceutical | Neovii Biotech NA, Inc. | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Be The Match Foundation | Oxford Immunotec | Amgen | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Otsuka Pharmaceutical

Authors: Junya Kanda, Ruta Brazauskas, Zhen-Huan Hu, Yachiyo Kuwatsuka, Koji Nagafuji, Heiwa Kanamori, Yoshinobu Kanda, Koichi Miyamura, Makoto Murata, Takahiro Fukuda, Hisashi Sakamaki, Fumihiko Kimura, Sachiko Seo, Mahmoud Aljurf, Ayami Yoshimi, Giuseppe Milone, William A. Wood, Celalettin Ustun, Shahrukh Hashimi, Marcelo Pasquini, Carmem Bonfim, Jignesh Dalal, Theresa Hahn, Yoshiko Atsuta, Wael Saber

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission

Journal Article published 24 Jan 2017 in Cancer volume 123 issue 11 on pages 2025 to 2034

Research funded by Novartis Pharmaceuticals Corporation | National Marrow Donor Program | National Cancer Institute (HHSH250201200016C) | Patient-Centered Outcomes Research Institute | Merck & Company, Inc. | Roswell Park Cancer Institute | Takeda Oncology | Medical College of Wisconsin | Leukemia and Lymphoma Society | Spectrum Pharmaceuticals, Inc. | Pfizer, Inc | Alexion Pharmaceuticals | Fred Hutchinson Cancer Research Center | WellPoint | Seattle Genetics | National Institute of Allergy and Infectious Diseases (grant/cooperative agreement 5U10HL069294) | Janssen Scientific Affairs, LLC | Center for International Blood and Marrow Transplantation (CIBMTR) | Sanofi US | Bristol Myers Squibb Oncology | Gamida Cell Ltd. | University of Minnesota | Perkin Elmer, Inc. | Otsuka Pharmaceutical Company, Ltd.-Japan | Onyx Pharmaceuticals | National Heart, Lung, and Blood Institute | Swedish Orphan Biovitrum, Inc. | Bluebird Bio, Inc | Optum Healthcare Solutions, Inc. | MesoScale Diagnostics, Inc. | Genentech | Mesoblast | Genzyme | Medac, GmbH | Miltenyi Biotec, Inc. | Public Health Service (grant/cooperative agreement 5U24-CA076518) | Telomere Diagnostics, Inc. | Sunesis Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Health Research | Gilead Sciences | Otsuka America Pharmaceutical | Neovii Biotech NA, Inc. | Health Resources and Services Administration (N00014-15-1-0848, N00014-16-1-2020) | Cellular Dynamics International, Inc. | Celgene | AstraZeneca | MedImmune | St. Baldrick's Foundation | Be The Match Foundation | Amgen | HistoGenetics, Inc. | Sunesis Pharmaceuticals | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | Astellas Pharma US | Incyte Corporation

Authors: Daniel J. Weisdorf, Heather R. Millard, Mary M. Horowitz, Parvinder S. Hyare, Richard Champlin, Vincent Ho, Marco Mielcarek, Andrew Rezvani, Keith Stockerl-Goldstein, Hanna J. Khoury, Marcos De Lima, Wael Saber, Brenda Sandmaier, Mei Jie Zhang, Mary Eapen

Lysosomal Acid Lipase Deficiency: Report of Five Cases across the Age Spectrum

Journal Article published 2018 in Case Reports in Pediatrics volume 2018 on pages 1 to 5

Research funded by Alexion Pharmaceuticals

Authors: Marco Antonio Curiati, Sandra Obikawa Kyosen, Vanessa Gonçalves Pereira, Francy Reis da Silva Patrício, Ana Maria Martins

SIPPET: methodology, analysis and generalizability

Journal Article published 17 Mar 2017 in Haemophilia volume 23 issue 3 on pages 353 to 361

Research funded by Ablynx | Alexion Pharmaceuticals | Kedrion Biopharma | Novo Nordisk

Authors: F. Peyvandi, P. M. Mannucci, R. Palla, F. R. Rosendaal